Extended dosing of darbepoetin alfa in peritoneal dialysis patients

BACKGROUND: Anemia is common among peritoneal dialysis (PD) patients, and most patients require erythropoiesis-stimulating agents (ESA) to maintain their hemoglobin concentrations within current guideline recommendations. Darbepoetin alfa is an ESA with a 3-fold longer half-life and greater in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Feriani, Mariano, De Meester, Johan MJ, McMahon, Lawrence P, Rottembourg, Jacques B, Bridges, Ian, Farouk, Mourad, Pronai, Wolfgang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072319/
https://www.ncbi.nlm.nih.gov/pubmed/21435267
http://dx.doi.org/10.1186/1471-2369-12-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072319/
https://www.ncbi.nlm.nih.gov/pubmed/21435267
http://dx.doi.org/10.1186/1471-2369-12-13

Ejemplares similares